We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.3B
AUM Growth
-$1.95B
Cap. Flow
-$2.03B
Cap. Flow %
-16.47%
Top 10 Hldgs %
23.48%
Holding
1,965
New
109
Increased
648
Reduced
914
Closed
286

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$24.9M
2
PLTR icon
Palantir
PLTR
+$24.7M
3
APP icon
Applovin
APP
+$16.8M
4
MSTR icon
Strategy Inc
MSTR
+$12.4M
5
HD icon
Home Depot
HD
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 28.64%
2 Consumer Discretionary 9.28%
3 Healthcare 7.92%
4 Communication Services 7.89%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
51
AbbVie
ABBV
$435B
$45.5M 0.37%
256,078
-22,449
-8% -$4.13M
INTU icon
52
Intuit
INTU
$89.7B
$44.8M 0.36%
71,271
-3,881
-5% -$2.48M
PLTR icon
53
Palantir
PLTR
$381B
$42.9M 0.35%
566,805
+423,969
+297% +$24.7M
MRVL icon
54
Marvell Technology
MRVL
$189B
$42.5M 0.34%
384,960
-19,510
-5% -$1.81M
VZ icon
55
Verizon
VZ
$193B
$42.3M 0.34%
1,057,615
-113,754
-10% -$4.8M
NEE icon
56
NextEra Energy
NEE
$179B
$41.2M 0.33%
574,794
+34,576
+6% +$2.69M
LULU icon
57
lululemon athletica
LULU
$14B
$41.2M 0.33%
107,733
+2,232
+2% +$729K
BMY icon
58
Bristol-Myers Squibb
BMY
$130B
$40.9M 0.33%
723,676
+2,398
+0.3% +$134K
SNPS icon
59
Synopsys
SNPS
$76.7B
$40.9M 0.33%
84,176
+5,484
+7% +$2.87M
JNJ icon
60
Johnson & Johnson
JNJ
$621B
$40.6M 0.33%
280,519
-29,341
-9% -$4.55M
ZTS icon
61
Zoetis
ZTS
$31.2B
$39.6M 0.32%
242,761
+7,497
+3% +$1.34M
CVX icon
62
Chevron
CVX
$366B
$39.3M 0.32%
271,507
-42,844
-14% -$6.56M
BLK icon
63
Blackrock
BLK
$176B
$38.8M 0.31%
37,876
-647
-2% -$657K
MDT icon
64
Medtronic
MDT
$110B
$38.7M 0.31%
484,991
-81,459
-14% -$7.05M
MRK icon
65
Merck
MRK
$317B
$38.5M 0.31%
387,396
+28,910
+8% +$2.98M
GS icon
66
Goldman Sachs
GS
$309B
$38.3M 0.31%
66,934
-6,086
-8% -$3.39M
MU icon
67
Micron Technology
MU
$1.01T
$37.1M 0.3%
440,933
+581
+0.1% +$59.1K
AEP icon
68
American Electric Power
AEP
$68.8B
$36.6M 0.3%
396,455
-59,422
-13% -$5.75M
CRM icon
69
Salesforce
CRM
$158B
$36.5M 0.3%
109,238
-12,873
-11% -$4.11M
SHY icon
70
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$35.9M 0.29%
437,823
+99,813
+30% +$8.21M
CMI icon
71
Cummins
CMI
$89.5B
$34.9M 0.28%
100,218
-5,565
-5% -$1.96M
DE icon
72
Deere & Co
DE
$165B
$34.9M 0.28%
82,296
-2,539
-3% -$1.07M
SYY icon
73
Sysco
SYY
$40.3B
$34.8M 0.28%
454,927
-86,982
-16% -$6.66M
JCI icon
74
Johnson Controls International
JCI
$93.1B
$34.8M 0.28%
440,373
-68,339
-13% -$5.48M
ADSK icon
75
Autodesk
ADSK
$50.7B
$34.2M 0.28%
115,791
+5,945
+5% +$1.76M

Similar funds

Guggenheim Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Guggenheim Capital held 1,965 positions worth $12.3B, down 14% from $14.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Guggenheim Capital withdrew a net $2.03B in Q4 2024, closing 286 positions and reducing 914 holdings. Its most notable exit was MGP Ingredients, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Guggenheim Capital opened a new position in iShares Core S&P 500 ETF worth $24.8M.

  • Guggenheim Capital's largest Q4 2024 buy was iShares Core S&P 500 ETF: 42,150 shares worth $24.8M.
  • Guggenheim Capital added most to Palantir in Q4 2024, an estimated $24.7M increase.
  • Guggenheim Capital's biggest Q4 2024 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $183M.
  • Guggenheim Capital fully exited MGP Ingredients in Q4 2024, selling an estimated $13.5M.
  • Guggenheim Capital's ten largest holdings make up 23% of its $12.3B portfolio in Q4 2024.
  • Guggenheim Capital opened 109 new positions and closed 286 in Q4 2024.
  • Guggenheim Capital's portfolio value fell 14% quarter-over-quarter to $12.3B.

Based on Guggenheim Capital's 13F filing for Q4 2024, filed 13 Feb 2025.